-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Marinus Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2015 to 2023.
- Marinus Pharmaceuticals, Inc. Depreciation for the quarter ending March 31, 2024 was $131K, a 16.6% decline year-over-year.
- Marinus Pharmaceuticals, Inc. annual Depreciation for 2023 was $551K, a 31.8% increase from 2022.
- Marinus Pharmaceuticals, Inc. annual Depreciation for 2022 was $418K, a 17.7% increase from 2021.
- Marinus Pharmaceuticals, Inc. annual Depreciation for 2021 was $355K, a 6.29% increase from 2020.
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)